Current Trials
Find out more about taking part in one of our trials
Find out more about taking part in an intervention treatment trial where you may receive a new treatment being tested for T1D. We also have information on monitoring trials where participants are observed/monitored, data is collected but there is no intervention/treatment.
Treatment Trials
IMPACT Study
Trial of a new medication in people with 1 diabetes aged 12-45. Screening visit to be conducted within 9 weeks of diagnosis.
PROTECT Study
The PROTECT Study is testing how well an investigational medicine works in children and adolescents with Type 1 diabetes (T1D).
Interleukin-2 Therapy of Autoimmunity in Diabetes (ITAD)
ITAD is a multicentre, randomised, double-blind, placebo-controlled clinical trial of to see if a drug called aldesleukin, can preserve insulin production in children and young adults recently diagnosed with type 1 diabetes.
Ver-A-T1D Study
A randomised, double-blind, placebo controlled, parallel group, multi-centre trial in adult subjects with newly diagnosed type 1 diabetes mellitus investigating the effect of Verapamil SR on preservation of beta-cell function (Ver-A-T1D)
MELD-ATG Trial
Trial of a new medication in people with 1 diabetes aged 12-45. Screening visit to be conducted within 9 weeks of diagnosis.
CFZ533X2207 Trial
Study of safety and efficacy of CFZ533 in children and young adults with new onset type 1 diabetes.
Monitoring Studies
Would you like to be involved in studies where you have more monitoring, so that researchers can find out more about type 1 diabetes?
Remote study investigating the progression of Type 1 diabetes in adults (18 years and over) within 100 days of diagnosis and insulin treated.
A research project for children and adults aged 1 or older and newly diagnosed with type 1 diabetes (within the last 6 months), to collect information about their diabetes, and inform them about other opportunities to take part in type 1 diabetes research. Siblings can help too.
A project throughout Europe which collects blood samples and data from newly diagnosed patients between 1 and 45 years who have been diagnosed with type 1 diabetes within the previous 6 weeks and their first degree relatives (brothers, sisters, parents or children).
With these data we can study the evolution of the disease in these individuals and develop new ways to predict the risk for relatives for developing the disease and eventually find a cure for those already diagnosed with the disease.
Ustekinumab in adolescents with new onset type 1 diabetes
Recruitment closed
Trial of a new medication in 12-18 year olds with Type 1 diabetes within 100 days of diagnosis
Research study for people with Type 1 Diabetes: EXALT
Recruitment closed
The main purpose of this study is to assess the safety of three different doses of an investigational drug in patients who have been recently diagnosed with type 1 diabetes.
The Effect of Abatacept on the Immune System in Type 1 Diabetes
Recruitment closed
This study aims to gain a better understanding of the immune processes that lead to the destruction of insulin producing beta cells.
The Effect of Anti-IL-21 and Liraglutide in Newly Diagnosed Type 1 Diabetes
Recruitment closed
This study will investigate if a new drug Anti-IL-21 when given together with another drug marketed for type 2 diabetes called liraglutide can preserve the beta cells in subjects diagnosed with type 1 diabetes.
Join our research and help change the future of Type 1 Diabetes
Twitter Feeds
This is a step in the right direction. Connecting efforts, expertise and resources should help advancing research of autoimmune conditions.
#T1D @JDRFUK @T1D_UK @Innodiagroup @EASDelearning @DiabetesUK @DiabetesUKCymru @britsocimm @T1DCCUK https://twitter.com/JDRFUK/status/1420683923617628166